A B S T R A C T On the basis of serial studies the responsiveness of leukocytes and lymphocytes from asthmatic donors to catecholamines was increased during high dose corticosteroid therapy. Similar changes were observed in the cells of normal control subjects given 200 mg of hydrocortisone intravenously. The increase in responsiveness did not appear to be due to changes in lymphocyte subpopulations although this may be a contributing factor. In an effort to elucidate the basis for the improved response, in vitro effects of gfucocorticoids on lymphocyte cyclic AMP concentrations were investigated. Glucocorticoids (prednisolone succinate, hydrocortisone, hydrocortisone phosphate, and hydrocortisone succinate) stimulated cyclic AMP accumulation in asthma and normal control lymphocytes, increases occurring within the first 2 min of incubation. In the absence of theophylline, responses were regularly obtained at 10 FM hydrocortisone and usually at 1 /LM hydrocortisone but not at submicromolar steroid concentrations. Theophylline potentiated the cyclic AMP response to glucocorticoids and also increased the percentage of positive responses in the 0.01-1.0 LM corticosteroid range. Combinations of 1 AsM hydrocortisone and 1 IM epinephrine were sometimes additive or synergistic but in many instances higher glucocorticoid concentrations were needed to obtain augmentation of the catecholamine response. The in vitro glucocorticoid effects may not fully explain their potentiating action in vivo.
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INTRODUCTION
The mechanism of action of glucocorticoids in bronchial asthma has long been a subject of controversy. Even in massive doses, corticosteroids appear to have little direct bronchodilator action and in the absence of concurrent sympathomimetic amine therapy are of limited benefit (1) . But in individuals who have failed to respond to large amounts of corticosteroids given alone, small amounts of beta adrenergic drugs have produced dramatic improvement, suggesting that glucocorticoids can amplify catecholamine responsiveness. Evidence for a catecholamine potentiating action of corticosteroids has been obtained in recent studies in experimental animals in vivo and in vitro (2, 3) . Ordinarily the improved catecholamine response appears to involve an enhancement of cellular enzyme responsiveness to the modulation effects of cyclic AMP (3, 4) but a direct effect on cyclic AMP accumulation has also been obtained, particularly in tissues from adrenalectomized animals (5, 6) . We have previously demonstrated that peripheral blood leukocytes and lymphocytes from individuals with bronchial asthma have a decreased cyclic AMP response to beta adrenergic drugs by comparison with cells from normal control subjects (7, 8) . In the present report the ability of corticosteroids to alter adrenergic responsiveness in these cells has been evaluated.
METHODS
Hydrocortisone, hydrocortisone-21-phosphafe, hydrocortisone-21-hemisuccinate, and prednisolone-21-hemisuccinate were obtained from the Sigma Chemical Co., St. Louis, Mo. Stock 10 mM corticosteroid solutions were freshly prepared in 95% ethanol and dilutions were made in 0.1 M NaCl. The maximal ethanol concentration used with cells was 1%o (vol: (8) (9) (10) .
RESULTS
Possible effects of systemic corticosteroid therapy on leukocyte and lymphocyte adrenergic responsiveness.
We have previously reported that when leukocytes from patients with active asthma receiving and not receiving systemic corticosteroid therapy were compared, the 10 mM isoproterenol response was somewhat greater in cells from steroid-treated patients (8 The lymphocytes of three asthmatic patients and four normal adult controls were studied for more acute changes in catecholamine responsiveness following one or two 100-mg intravenous injections of hydrocortisone (Table II) . In very instance the 10 mM isoproterenol response improved markedly within several hours, the increase ranging from 66-250%. Similar increases occurred in lymphocyte responses to 1 mM isoproterenol, 0.1 mM isoproterenol, 1 AM epinephrine-0.5 mM theophylline, and 10 mM isoproterenol-0.5 mM theophylline (Table III ). An increased cyclic AMP response was also obtained with 30 jAM prostaglandin E1 (PGEs) indicating that the alteration in the cyclic AMP response in association with corticosteroid therapy is not restricted to catecholamines. Cyclic AMP concentrations in unstimulated cells were also increased but to a lesser extent.
As expected the sizable intravenous hydrocortisone dosages used in the acute experiments produced an absolute lymphocytopenia raising the possibility of a quantitative change in lymphocyte subpopulations. The The ratio of thymus and bone marrow derived lymphocytes (T and B cells) was enumerated by indirect immunofluorescence reacting cells initially with a mixture of rabbit antibodies specific for human IgG and IgM or IgG alone. Fluorescein-tagged goat anti-rabbit IgG was used as the second antibody. Following hydrocortisone injection the percentage of immunoglobulin containing lymphocytes (presumably B cells) increased in each of three normal subjects (mean increase 88%) and in one of two asthmatic subjects (mean increase 29%) for whom data are available (Table II) . In individuals
Responses to Steroids After drawing an initial blood specimen (before hydrocortisone) subjects were given 100 mg hydrocortisone phosphate intravenously. The 100 mg hydrocortisone injection was repeated after 100 min. Lymphocytes were purified by Ficoll-Hypaque centrifugation. Table II . Cells were obtained before and 150 min after the first of two injections of hydrocortisone (see Table II ). Responses of normal control lymphocytes to corticosteroids in vitro. In an attempt to elucidate how corticosteroid therapy might alter lymphocyte responsiveness to isoproterenol the effect of adding corticosteroids to normal lymphocytes in vitro was studied. In 30-min incubation experiments an increase in cyclic AMP concentration was regularly obtained at 10 MM hydrocortisone and frequently at 1 MAM hydrocortisone (Table IV) . Increases were also observable at earlier times (2, 5, and 10 min) and with other glucocorticoids (prednisolone and two water-soluble hydrocortisone derivatives). A greater cyclic AMP response was obtained at 30 than at 5 min in two experiments but no difference in two others (not shown). With an incubation period of 2 h the corticosteroid response was similar to or less than that obtained at 30 min (three experiments). The glucocorticoid response was not blocked by propranolol (at Fig. 1) . In other experiments hydrocortisone either did not potentiate the epinephrine-theophylline response or did so only at concentrations of 5 /AM or higher (see, for example, the experiment denoted by open circles in Fig. 1 ). In three experiments in which potentiation of the epinephrine response by hydrocortisone was obtained, data at shorter incubation times are also available. In two of the three In normal control cells amplification of the epinephrine response at low hydrocortisone concentrations was also observed, although to a lesser extent than in cells from asthmatic donors. At high (100 /AM), nonpharmacologic hydrocortisone concentrations a paradoxical effect was sometimes obtained in which the two agents in combination produced a smaller rise in cyclic AMP than either agent alone.
Despite the impressive potentiation of epinephrine stimulation by hydrocortisone in some experiments, more frequently marked changes in the catecholamine response were not observed. The possibility was considered that corticosteroids might exert a delayed effect on adrenergic responsiveness in addition to whatever changes were obtained in short incubation experiments. Three preparations of asthma lymphocytes and three of normal control lymphocytes in which hydroocrtisone did not augment epinephrine or isoproterenol responsiveness in 10 and 30 min incubation experiments were studied.
Preincubation of these cells with pharmacologic concentrations of hydrocortisone for 30 and 120 min did not increase the catecholamine response. Representative data are given in Table V. The ability of hydrocortisone to potentiate the catecholamine response in beta blocked (d,-propranolol) normal control cells also was studied (three experiments, one of which is shown in Table VI ). Essentially negative results were obtained.
DISCUSSION
The results of these studies indicate that pharmacologic concentrations of corticosteroids are capable of promoting the accumulation of cyclic AMP in human lymphocytes in vitro, confirming our earlier observations at higher corticosteroid concentrations (7) . Similar observations have recently been reported by Logsdon, Middleton, and Coffey in mixed human leukocytes using a radioactive precursor method for measuring cyclic AMP formation (11) . A significant difference between the two studies is the greater variability we have observed in the ability of 1 /sM hydrocortisone to raise lymphocyte cyclic AMP concentrations in preparations from different individuals. As a rule the pattern of responsiveness is reproducible in a given individual raising the possibility of a genetic influence on the response. Whether in vitro corticosteroid responsivenes is in any way a reflection of corticosteroid reactivity in vivo remains to be established. It will be of interest to correlate the results of in vitro studies with corticosteroid effects on glucose tolerance, blood pressure, and intraocular pressure in vivo.
The mechanism by which corticosteroids alter lymphocyte cyclic AMP metabolism and improve catecholamine responsiveness will require further study. Effects are observable at 2-5 min and maximal within 5- (12, 15) and in corticosteroid treated mice there is selective trapping of thymus derived lymphocytes in the bone marrow (12, 16) . The possibility that a change in the proportion of T and B lymphocytes might be involved when leukocytes from individuals receiving corticosteroid therapy showed altered hormonal responsiveness was not studied by Logsdon et al. (11) who assumed that most of the cyclic AMP response was taking place in polymorphonuclear leukocytes. Our own observations indicate the proportion of B lymphocytes does increase significantly during corticosteroid therapy and we cannot exclude the possibility that such changes partially explain the improvement in hormonal responsiveness. However, we doubt that this is the sole explanation since the increase in hormonal responsiveness sometimes exceeds the increase in percentage of circulating B cells by a considerable margin.
In view of the increased hormonal responsiveness in cells from corticosteroid treated individuals it is tempting to speculate that corticosteroids might alter catecholamine responsiveness in lung in much the same way, accounting for the beneficial effect of these agents in bronchial asthma. Townley and his colleagues have reported that corticosteroids increase beta adrenergic responsiveness in human tracheal muscle preparations exposed to dl-propanolol (17, 18) . However, 100 uM corticosteroid concentrations were used and concentrations of this magnitude would not be obtained in vivo, even during massive corticosteroid therapy. It should also be kept in mind that individuals with acute asthmatic attacks do not necesarily have evidence for altered adrenergic responsiveness in the lymphocyte assay even though corticosteroids are effective in this situation. In addition to a corticosteroid action on cyclic AMP metabolism, possible corticosteroid effects on cellular responsiveness to cyclic AMP, catecholamine biosynthesis and release, and immunological mediator release in this situation also merit careful study. ACKNOWLEDGMENTS This work was supported by grants from the National Institutes of Health.
